P/E ratio for Aspen Pharmacare (APN.JO)
P/E ratio at the end of 2022: 8.75
According to Aspen Pharmacare's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.4151. At the end of 2022 the company had a P/E ratio of 8.75.
P/E ratio history for Aspen Pharmacare from 2003 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 8.75 | -25.69% |
| 2021 | 11.8 | -10.96% |
| 2020 | 13.2 | 134.93% |
| 2019 | 5.63 | -61.15% |
| 2018 | 14.5 | -17.54% |
| 2017 | 17.6 | -42.29% |
| 2016 | 30.4 | 42.3% |
| 2015 | 21.4 | 40.9% |
| 2014 | 15.2 | -2.31% |
| 2013 | 15.5 | 80.85% |
| 2012 | 8.59 | 66.09% |
| 2011 | 5.17 | -19.21% |
| 2010 | 6.41 | 2.39% |
| 2009 | 6.26 | 9.39% |
| 2008 | 5.72 | -15.51% |
| 2007 | 6.77 | -8.24% |
| 2006 | 7.38 | -53.31% |
| 2005 | 15.8 | 276.11% |
| 2004 | 4.20 | 21.57% |
| 2003 | 3.46 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.